Enhanced gefitinib cytotoxicity in the presence of cyclodextrins: in-vitro and biophysical studies towards potential therapeutic interventions for cancer

K Hatziagapiou, K Bethanis, GI Lambrou… - Journal of …, 2017 - ingentaconnect.com
Gefitinib (Iressa®) is an inhibitor of EGFR tyrosine kinase, used in the treatment of lung and
other cancers. Its efficient use is severely hampered by very low solubility in water which can …
被引用次数：10 相关文章

[引用][C] Enhanced Gefitinib Cytotoxicity in the Presence of Cyclodextrins: In-Vitro and Biophysical Studies Towards Potential Therapeutic Interventions for Cancer

K Hatziagapiou, K Bethanis, GI Lambrou… - Journal of Biomedical …, 2017 - cir.nii.ac.jp
Enhanced Gefitinib Cytotoxicity in the Presence of Cyclodextrins: <i>In-Vitro</i> and
Biophysical Studies Towards Potential Therapeutic Interventions for Cancer | CiNii Research …

Enhanced gefitinib cytotoxicity in the presence of cyclodextrins: In-vitro and biophysical studies towards potential therapeutic interventions for cancer

K Hatziagapiou, K Bethanis… - Journal of …, 2017 - researchprofiles.herts.ac.uk
Gefitinib (Iressa®) is an inhibitor of EGFR tyrosine kinase, used in the treatment of lung and
other cancers. Its efficient use is severely hampered by very low solubility in water which can …